share_log

Delivra Health Brands' Dream Water(R) Brand Launches Its Sleep Gummies Into the Canadian Market

Delivra Health Brands' Dream Water(R) Brand Launches Its Sleep Gummies Into the Canadian Market

Delivra Health Brands 的 Dream Water (R) 品牌向加拿大市場推出睡眠軟糖
newsfile ·  02/21 20:20

Vancouver, British Columbia--(Newsfile Corp. - February 21, 2024) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) ("Delivra Health" or the "Company"), a consumer packaged goods company uniquely positioned in the health and wellness sector, is pleased to announce that its Dream Water brand will be launching a new line of sleep gummies in the Canadian market. Sleep Gummies are expected to be available to Company distributors, retailers and e-commerce channels in June 2024.

不列顛哥倫比亞省溫哥華--(Newsfile Corp.,2024 年 2 月 21 日)— Delivra Health Brands Inc.(多倫多證券交易所股票代碼:DHB)(場外交易代碼:DHBUF)(”德利維拉健康“或者”公司“)是一家在健康和保健領域處於獨特地位的包裝消費品公司,很高興地宣佈,其Dream Water品牌將在加拿大市場推出新的睡眠軟糖系列。Sleep Gummies預計將於2024年6月向公司的分銷商、零售商和電子商務渠道上市。

The launch of Dream Water Sleep Gummies in Canada is a significant milestone for the Company and will contribute to the Company's sales growth plan and brand expansion in North America. The product will be available through Delivra Health's national distribution partners in both retail and e-commerce channels and will improve Dream Water's overall channel penetration by leveraging the Company's expertise in branding, marketing, and distribution. Furthermore, this extension into a new functional format will allow the Dream Water brand to meet the changing trends in consumer behavior.

Dream Water Sleep Gummies在加拿大的推出對公司來說是一個重要的里程碑,將爲公司在北美的銷售增長計劃和品牌擴張做出貢獻。該產品將通過Delivra Health的全國分銷合作伙伴在零售和電子商務渠道上市,並將利用該公司在品牌、營銷和分銷方面的專業知識提高Dream Water的整體渠道滲透率。此外,這種對新功能格式的擴展將使Dream Water品牌能夠滿足消費者行爲不斷變化的趨勢。

"We are pleased to announce that Dream Water Sleep Gummies have been approved by Health Canada and will be available in Canadian retail and e-commerce locations in June of 2024," said Gord Davey, President and Chief Executive Officer of Delivra Health Brands. "The Canadian launch extends the success we have seen with this product in the United States in channels such as e-commerce, grocery, convenience and travel outlets, including all major US airports. We plan to continue our global rollout of Dream Water products and provide Dream Water Sleep Gummies to more territories in the near future."

Delivra Health Brands總裁兼首席執行官戈德·戴維表示:“我們很高興地宣佈,Dream Water Sleep Gummies已獲得加拿大衛生部的批准,並將於2024年6月在加拿大的零售和電子商務場所上市。”“加拿大的推出延續了我們在美國電子商務、雜貨店、便利店和旅遊網點(包括美國所有主要機場)等渠道上取得的成功。我們計劃繼續在全球推出Dream Water產品,並在不久的將來向更多地區提供Dream Water Sleep Gummies。”

About Delivra Health Brands Inc.

關於 Delivra 健康品牌公司

Helping people take control of their health with alternative wellness solutions is what energizes the Delivra Health team! The Delivra Health portfolio features innovative brands like Dream Water and LivRelief, which deliver relief from common everyday issues like chronic pain, anxiety, and sleeplessness. Delivra Health products have allowed millions of customers to reclaim their mobility, energy, and in turn, quality of life. The websites of the Company's two subsidiaries are Dream Water and LivReliefTM. For more information, please visit .

通過其他健康解決方案幫助人們控制自己的健康是Delivra Health團隊充滿活力的動力!Delivra Health產品組合以Dream Water和LivRelief等創新品牌爲特色,可緩解慢性疼痛、焦慮和失眠等常見的日常問題。Delivra Health 產品使數百萬客戶能夠恢復出行能力、活力,進而提高生活質量。公司兩家子公司的網站是夢之水和 LivReliefTM。欲了解更多信息,請訪問。

Cautionary Note Regarding Forward-Looking Statements

關於前瞻性陳述的警示說明

This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates, and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements include, among other things, statements with respect to the timing of when the Dream Water Sleep Gummies are expected to be available in Canada, any future rollouts of Dream Water products, the Company's products offering relief from chronic pain, anxiety, and sleeplessness, expectations regarding increase of the Company's revenues and profitability, the Company's growth objectives, increasing revenues and profitability, growth in new markets, and new distribution partners.

本新聞稿包含適用的加拿大證券立法所指的 “前瞻性信息” 和 “前瞻性陳述”(統稱爲 “前瞻性陳述”)。除歷史事實陳述外,所有陳述均爲前瞻性陳述,基於截至本新聞發佈之日的預期、估計和預測。任何涉及對預測、期望、信念、計劃、預測、目標、假設、未來事件或績效的討論的陳述(通常但並非總是使用 “期望”、“不期望”、“預期” 或 “不預期”、“計劃”、“預算”、“預算”、“預期”、“預測”、“估計”、“相信” 或 “打算” 等詞語或此類詞語的變體)以及短語或陳述 “可能” 或 “可能”、“將”、“可能” 或 “將” 發生或實現的某些行動、事件或結果)不是陳述歷史事實,可能是前瞻性陳述。在本新聞稿中,前瞻性陳述除其他外包括有關Dream Water Sleep Gummies預計在加拿大上市的時間安排、Dream Water產品的未來推出、公司緩解慢性疼痛、焦慮和失眠的產品、對公司收入和盈利能力增加的預期、公司的增長目標、增加收入和盈利能力、新市場的增長以及新的分銷合作伙伴的陳述。

These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance, or achievements of the Company to materially differ from any future results, performance, or achievements expressed or implied by such forward-looking statements. Such factors, among other things, include: fluctuations in general macroeconomic conditions; fluctuations in securities markets; expectations regarding the size of the cannabis markets where the Company operates; changing consumer habits; the ability of the Company to successfully achieve its business objectives; plans for expansion; political and social uncertainties; inability to obtain adequate insurance to cover risks and hazards; employee relations and the presence of laws and regulations that may impose restrictions on cultivation, production, distribution, and sale of cannabis and cannabis-related products in the markets where the Company operates. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.

這些前瞻性陳述基於發表此類陳述時公司管理層的合理假設和估計。未來的實際業績可能存在重大差異,因爲前瞻性陳述涉及已知和未知的風險、不確定性和其他因素,這些因素可能導致公司的實際業績、業績或成就與此類前瞻性陳述所表達或暗示的任何未來業績、業績或成就存在重大差異。這些因素包括:總體宏觀經濟狀況的波動;證券市場的波動;對公司經營的大麻市場規模的預期;消費者習慣的改變;公司成功實現業務目標的能力;擴張計劃;政治和社會不確定性;無法獲得足夠的保險來承保風險和危險;員工關係以及可能限制種植、生產、分銷的法律和法規的存在,以及在公司經營的市場上銷售大麻和大麻相關產品。儘管本新聞稿中包含的前瞻性陳述基於公司管理層當時認爲或認爲的合理假設,但公司無法向股東保證實際業績將與此類前瞻性陳述一致,因爲可能還有其他因素導致業績與預期、估計或預期不符。讀者不應過分依賴本新聞稿中包含的前瞻性陳述和信息。除非法律要求,否則公司沒有義務在信念、觀點、預測或其他因素的前瞻性陳述發生變化時對其進行更新。

Additional information regarding this and other risks and uncertainties relating to the Company's business are contained under the heading "Risk Factors" in the Company's annual information form dated March 2, 2021, and under the heading "Risks and Uncertainties" in the Company's management's discussion and analysis dated November 28, 2023 for the three months ended September 30 2023, filed under the Company's profile on SEDAR+ at .

有關該風險以及與公司業務相關的其他風險和不確定性的其他信息包含在公司2021年3月2日的年度信息表中 “風險因素” 標題下,以及公司管理層於2023年11月28日根據公司在SEDAR+的簡介提交的截至2023年9月30日的三個月的討論和分析中的 “風險和不確定性” 標題下。

Neither TSX-V nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) accept responsibility for the adequacy or accuracy of this release.

TSX-V 及其監管服務提供商(該術語在 TSX-V 的政策中定義)均不對本新聞稿的充分性或準確性承擔責任。

Investor Relations:
Jack Tasse
Chief Financial Officer
IR@delivrahealth.com
1-877-915-7934

投資者關係:
傑克·塔斯
首席財務官
IR@delivrahealth.com
1-877-915-7934

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論